PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-12-12 (1)

Date Title Company
12-Dec-2023 Maze Therapeutics Announces FTC Action Seeking to Block Collaboration and License Agreement with Sanofi Regarding MZE001, a Potential Oral Substrate Reduction Therapy for Pompe Disease Businesswire